A new microbiological problem in intensive care units: Environmental contamination by MRSA with reduced susceptibility to glycopeptides

International Journal of Hygiene and Environmental Health

Volumn 211, Issue 1-2, 2008, Pages 213-218

  Perdelli, Fernanda ^a   Dallera, Maurizio ^a   Cristina, Maria Luisa ^a   Sartini, Marina ^a   Ottria, Gianluca ^a   Spagnolo, Anna Maria ^a   Orlando, Paolo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Environmental monitoring; hGISA; Intensive care unit

Indexed keywords

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 39049157295     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2007.04.002     Document Type: Article

References (17)

1. Acar J.F., Kaplan E.L., and O'Brien T.F. Monitoring and management of bacterial resistance to antimicrobial agents, a world health organization symposium. Clin. Infect. Dis. 24 suppl 1 (1997) 1-176
2. Ariza J., Pujol M., Cabo J., Pena C., Fernandez N., Linares J., et al. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 353 (1999) 1587-1588
3. Boccia D., D'Ancona F., and Pantosti A. Resistenza alla Vancomicina in ceppi invasivi di enterococcus faecalis ed enterococcus faecium. Dati preliminari. BEN - Notiziario ISS 15 (2002) 5
4. Byers K.E., Durbin L.J., Simonton B.M., Anglim A.M., Adal K.A., and Farr B.M. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect. Control Hosp. Epidemiol. 19 (1998) 261-264
5. Dancer S.J. How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals. J. Hosp. Infect. 56 (2004) 10-15
6. Dietze B., Raht A., Wendt C., and Martiny H. Survival of MRSA on sterile goods packaging. J. Hosp. Infect. 49 (2001) 255-261
7. Farr B.M., Salgado C.D., Karchmer T.B., and Sherertz R.J. Can antibiotic-resistant nosocomial infections be controlled?. Lancet Infect. Dis. 1 (2001) 38-45
8. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., and Tenover F.C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemoth. 40 (1997) 135-136
9. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1 (2001) 147-155
10. Howe R.A., Monk A., Wootton M., Walsh T.R., and Enright M.C. Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerging Infect. Dis. 10 (2004) 855-857
11. Linares J. VISA/GISA problem: therapeutic implications. Clin. Microbiol. Infect. 7 Suppl 4 (2001) 8-15
12. Moore M.R., Perdreau-Remington F., and Chambers H.F. Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in patient with endocarditis and in the rabbit model of endocarditis. Antimicrob. Agents Chemoth. 47 (2003) 1262-1266
13. National Committee for Clinical Laboratory Standards, 2002. Performance standards for antimicrobial susceptibility test. 12th Informational Supplement M100-S12, 22: 1. Wayne, PA: NCCLS.
14. Walsh T.R., Bolmstrom A., Qwarnstrom A., Ho P., Wotton M., Howe R.A., et al. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39 (2001) 2439-2444
15. Walsh T.R., Howe R.A., Wootton M., Bennett P.M., and MacGowan P. Detection of glycopeptide resistance in Staphylococcus aureus. J. Antimicrob. Chemoth. 47 (2001) 357-358
16. Wenzel R.P., and Edmond M.B. Vancomycin - resistant Staphylococcus aureus: infection control considerations. Clin. Infect. Dis. 27 (1998) 245-251
17. Wootton M., Howe R.A., Hillman R., Walsh T.R., Bennett P.M., and MacGowan A.P. A modified population analysis profile method to detect Staphylococcus aureus with decreased susceptibilities to vancomycin in UK hospital. J. Antimicrob. Chemoth. 47 (2001) 399-404